Trial Profile

Treatment of Bladder Pain Syndrome with Onabotulinum toxin A

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 02 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Botulinum-Toxin-A (Primary)
Indications Bladder disorders; Interstitial cystitis; Pain
Focus Therapeutic Use
Acronyms ProBaBle

Most Recent Events

31 Aug 2024 Status changed from recruiting to completed.
16 May 2017 Results (n=19) presented at the 112th Annual Meeting of the American Urological Association
16 Sep 2016 Primary endpoint has been met (Absolute variation of pain intensity in pain VAS from visit 1 (screening) to visit 6 (week 12)), according to the interim results.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com